XCLEIC
LIVE

Serial Number

90720596

Owner

Seqirus Inc.

Attorney

Nancy Sabarra

Filing Date

May 19, 2021

Add to watchlist:

No watchlists yet
View on USPTO

XCLEIC Trademark

Serial Number: 90720596

XCLEIC is a trademark filed by Seqirus Inc. on May 19, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Seqirus Inc. (70 trademarks)

475 Green Oaks Parkway
Holly Springs, NC 27540

Entity Type: 03

Trademark Details

Filing Date

May 19, 2021

Registration Date

Not Registered

Published for Opposition

April 4, 2023

Goods & Services

Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use

Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals

Medical services; medical information; providing a website featuring medical information

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2025 EXRA
SOU EXTENSION 5 GRANTED
Nov 26, 2025 EX5G
SOU TEAS EXTENSION RECEIVED
Nov 24, 2025 EEXT
SOU EXTENSION 5 FILED
Nov 23, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 16, 2025 EX4G
SOU EXTENSION 4 FILED
May 16, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 11, 2024 EXRA
SOU EXTENSION 3 GRANTED
Dec 11, 2024 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2024 AITU
SOU EXTENSION 3 FILED
Nov 12, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 22, 2024 EX2G
SOU EXTENSION 2 FILED
May 22, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 22, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 23, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 21, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 21, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 21, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 1, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 1, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 1, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 1, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 31, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 31, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 31, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 4, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 4, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 4, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2021 NWOS
NEW APPLICATION ENTERED
May 22, 2021 NWAP